{"transactions":[{"id":4623425,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-21T20:33:26.000Z","date":"2026-09-17","kind":"gift","planned":false,"acquired":false,"shares":20445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 17th, the reporting person transferred 20,445 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On September 17th, the reporting person transferred 20,445 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust."}],"balance_after":75077,"source":{"system":"sec-edgar","filing":"0001628280-26-062915","document":"wk-form4_1790022803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026062915/wk-form4_1790022803.xml","form_type":"4"}},{"id":4616847,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-09-14T20:10:38.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":false,"shares":20445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is vested and currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.45,"expiration_date":"2026-11-23","underlying":"Class A Common Stock","underlying_shares":20445},"source":{"system":"sec-edgar","filing":"0001628280-26-061836","document":"wk-form4_1789416635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026061836/wk-form4_1789416635.xml","form_type":"4"}},{"id":4616846,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-14T20:10:38.000Z","date":"2026-09-11","kind":"exercise","planned":false,"acquired":true,"shares":20445,"price":14.45,"value":295430.25,"ownership":{"direct":true},"balance_after":95522,"source":{"system":"sec-edgar","filing":"0001628280-26-061836","document":"wk-form4_1789416635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026061836/wk-form4_1789416635.xml","form_type":"4"}},{"id":688021,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-08-13T20:21:02.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":false,"shares":168573,"price":17.18,"value":2896084.14,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.07 to $17.31 per share, inclusive. The Reporting Person\nundertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth in the footnote."}],"balance_after":93499,"source":{"system":"sec-edgar","filing":"0001628280-26-056752","document":"wk-form4_1786652460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026056752/wk-form4_1786652460.xml","form_type":"4"}},{"id":722831,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T20:20:56.000Z","date":"2026-06-29","kind":"gift","planned":false,"acquired":false,"shares":51813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person transferred 51,813 shares of Benitec Biopharma Inc. common stock to a donor-advised fund sponsored by a charitable organization under Section 501(c)(3) of the Internal Revenue Code."}],"balance_after":52097,"source":{"system":"sec-edgar","filing":"0001193125-26-290586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000119312526290586/ownership.xml","form_type":"4"}},{"id":786874,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:29:14.000Z","date":"2026-05-06","kind":"grant","planned":false,"acquired":true,"shares":19824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":19824,"derivative":{"underlying":"Class A Common Stock","underlying_shares":19824},"source":{"system":"sec-edgar","filing":"0001628280-26-032929","document":"wk-form4_1778272151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032929/wk-form4_1778272151.xml","form_type":"4"}},{"id":786873,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-08T20:29:14.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":false,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-26-032929","document":"wk-form4_1778272151.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032929/wk-form4_1778272151.xml","form_type":"4"}},{"id":786872,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-05-08T20:29:14.000Z","date":"2026-05-07","kind":"exercise","planned":false,"acquired":true,"shares":34819,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":75077,"source":{"system":"sec-edgar","filing":"0001628280-26-032929","document":"wk-form4_1778272151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828026032929/wk-form4_1778272151.xml","form_type":"4"}},{"id":981673,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2025-12-03T21:16:17.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026."}],"balance_after":35000,"derivative":{"exercise_price":12.23,"expiration_date":"2035-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001012975-25-000847","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000847/form4.xml","form_type":"4"}},{"id":1155101,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-08T23:54:08.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":34819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the\nfirst anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of the stockholders following the date of grant and (ii) the day immediately following the\nfirst anniversary of the date of grant."}],"balance_after":34819,"derivative":{"underlying":"Class A Common Stock","underlying_shares":34819},"source":{"system":"sec-edgar","filing":"0001628280-25-024004","document":"wk-form4_1746748442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025024004/wk-form4_1746748442.xml","form_type":"4"}},{"id":1155100,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-08T23:54:08.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":false,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 2, 2024, the reporting person was granted 40,258 restricted stock units vesting on May 5, 2025."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0001628280-25-024004","document":"wk-form4_1746748442.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025024004/wk-form4_1746748442.xml","form_type":"4"}},{"id":1155099,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-08T23:54:08.000Z","date":"2025-05-05","kind":"exercise","planned":false,"acquired":true,"shares":40258,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":40258,"source":{"system":"sec-edgar","filing":"0001628280-25-024004","document":"wk-form4_1746748442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025024004/wk-form4_1746748442.xml","form_type":"4"}},{"id":1207864,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-13T20:43:09.000Z","date":"2025-03-12","kind":"gift","planned":false,"acquired":true,"shares":103626,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On March 12, 2025, the reporting person gifted 103,626 shares of Common Stock to a trust for no consideration. The reporting person is trustee of the trust and the reporting person's son is the sole beneficiary."}],"balance_after":103626,"source":{"system":"sec-edgar","filing":"0001062993-25-005393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299325005393/form4.xml","form_type":"4"}},{"id":1207863,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-13T20:43:09.000Z","date":"2025-03-12","kind":"gift","planned":false,"acquired":false,"shares":103626,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":284,"source":{"system":"sec-edgar","filing":"0001062993-25-005393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299325005393/form4.xml","form_type":"4"}},{"id":1209683,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-12T20:11:47.000Z","date":"2025-03-10","kind":"gift","planned":false,"acquired":false,"shares":262072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 10, 2025, reporting person gifted 262,072 shares of Class A Common Stock to a trust for no consideration.  The Reporting person is trustee of the trust, and the son of the reporting person is the sole beneficiary."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"On March 10, 2025, reporting person gifted 262,072 shares of Class A Common Stock to a trust for no consideration.  The Reporting person is trustee of the trust, and the son of the reporting person is the sole beneficiary."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-25-012344","document":"wk-form4_1741810301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828025012344/wk-form4_1741810301.xml","form_type":"4"}},{"id":1236021,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrants (right to buy)","published_at":"2025-03-03T19:20:29.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":51813,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":51813},"source":{"system":"sec-edgar","filing":"0001062993-25-004077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299325004077/form4.xml","form_type":"4"}},{"id":1236020,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-03T19:20:29.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":51813,"price":3.86,"value":199998.18,"ownership":{"direct":true},"balance_after":103910,"source":{"system":"sec-edgar","filing":"0001062993-25-004077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299325004077/form4.xml","form_type":"4"}},{"id":1335786,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2024-12-11T22:22:01.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025."}],"balance_after":35000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-24-020468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324020468/form4.xml","form_type":"4"}},{"id":1517597,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-14T20:41:26.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":false,"shares":76453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 9, 2023, the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 9, 2023, the reporting person was granted 76,453 restricted stock units vesting on May 10, 2024."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":76453},"source":{"system":"sec-edgar","filing":"0001628280-24-023247","document":"wk-form4_1715719263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024023247/wk-form4_1715719263.xml","form_type":"4"}},{"id":1517596,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-14T20:41:26.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":true,"shares":76453,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":262072,"source":{"system":"sec-edgar","filing":"0001628280-24-023247","document":"wk-form4_1715719263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024023247/wk-form4_1715719263.xml","form_type":"4"}},{"id":1526379,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-06T21:23:27.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":40258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":40258,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40258},"source":{"system":"sec-edgar","filing":"0001628280-24-020722","document":"wk-form4_1715030598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000162828024020722/wk-form4_1715030598.xml","form_type":"4"}},{"id":1719125,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2023-12-08T00:55:51.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":3.1301,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001062993-23-022118","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299323022118/form4.xml","form_type":"4"}},{"id":1808680,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrants (right to buy)","published_at":"2023-08-14T21:10:56.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":51813,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."}],"balance_after":51813,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":51813},"source":{"system":"sec-edgar","filing":"0000950170-23-042536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000095017023042536/ownership.xml","form_type":"4"}},{"id":1808679,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-14T21:10:56.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":51813,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported number of shares has been adjusted to reflect the impact of the Issuer's 17-for-1 reverse stock split completed on July 26, 2023."}],"balance_after":52097,"source":{"system":"sec-edgar","filing":"0000950170-23-042536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000095017023042536/ownership.xml","form_type":"4"}},{"id":1857118,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-13T12:07:57.000Z","date":"2023-06-09","kind":"purchase","planned":false,"acquired":true,"shares":21858,"price":0.2875,"value":6284.175,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average.  Shares were purchased in multiple transactions at prices ranging from $0.2751 to $0.30, inclusive."}],"balance_after":146858,"source":{"system":"sec-edgar","filing":"0001615594-23-000047","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411906/000161559423000047/primary_doc.xml","form_type":"4"}},{"id":1860384,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T14:26:37.000Z","date":"2023-06-08","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.296,"value":7400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average.  The shares were purchased in multiple transactions at prices ranging from $0.29 to $0.30, inclusive."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001615594-23-000046","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411906/000161559423000046/primary_doc.xml","form_type":"4"}},{"id":1888741,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T16:25:20.000Z","date":"2023-05-16","kind":"purchase","planned":false,"acquired":true,"shares":32534,"price":0.2743,"value":8924.0762,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average.  Shares were purchased in multiple transactions at prices ranging from $0.2601 to $0.279, inclusive."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001615594-23-000033","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411906/000161559423000033/primary_doc.xml","form_type":"4"}},{"id":1891351,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T15:30:59.000Z","date":"2023-05-15","kind":"purchase","planned":false,"acquired":true,"shares":44026,"price":0.2466,"value":10856.8116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average.  Shares were purchased in multiple transactions at prices ranging from $0.227 to $0.2598, inclusive."}],"balance_after":67466,"source":{"system":"sec-edgar","filing":"0001615594-23-000032","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411906/000161559423000032/primary_doc.xml","form_type":"4"}},{"id":1891350,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T15:30:59.000Z","date":"2023-05-12","kind":"purchase","planned":false,"acquired":true,"shares":23440,"price":0.2352,"value":5513.088,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average.  Shares were purchased in multiple transactions at prices ranging from $0.228 to $0.244, inclusive."}],"balance_after":23440,"source":{"system":"sec-edgar","filing":"0001615594-23-000032","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411906/000161559423000032/primary_doc.xml","form_type":"4"}},{"id":1896760,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-11T20:15:22.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":80128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 9, 2022 the reporting person was granted 80,128 restricted stock units vesting on May 10, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80128},"source":{"system":"sec-edgar","filing":"0001209191-23-028734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028734/doc4.xml","form_type":"4"}},{"id":1896759,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-11T20:15:22.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":76453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":76453,"derivative":{"underlying":"Class A Common Stock","underlying_shares":76453},"source":{"system":"sec-edgar","filing":"0001209191-23-028734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028734/doc4.xml","form_type":"4"}},{"id":1896758,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-05-11T20:15:22.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":80128,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":185619,"source":{"system":"sec-edgar","filing":"0001209191-23-028734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919123028734/doc4.xml","form_type":"4"}},{"id":2091228,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2022-12-10T00:22:03.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":0.1682,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-023659","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299322023659/form4.xml","form_type":"4"}},{"id":2276244,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:42:51.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":80128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":80128,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80128},"source":{"system":"sec-edgar","filing":"0001209191-22-028155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028155/doc4.xml","form_type":"4"}},{"id":2276243,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-10T22:42:51.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":35406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35406},"source":{"system":"sec-edgar","filing":"0001209191-22-028155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028155/doc4.xml","form_type":"4"}},{"id":2276242,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-05-10T22:42:51.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":35406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":105491,"source":{"system":"sec-edgar","filing":"0001209191-22-028155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919122028155/doc4.xml","form_type":"4"}},{"id":2454099,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-03T20:12:22.000Z","date":"2021-12-30","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 1/12 monthly on the 30th of each month for one year (until December 30, 2022)."}],"balance_after":75000,"derivative":{"exercise_price":0.56,"expiration_date":"2031-12-30","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-22-000087","document":"form4-01032022_050107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411906/000141588922000087/form4-01032022_050107.xml","form_type":"4"}},{"id":2456924,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:18:42.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":30.47,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001399529-21-000195","document":"wf-form4_164081270887814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000195/wf-form4_164081270887814.xml","form_type":"4"}},{"id":2456923,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:18:42.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":21.61,"underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001399529-21-000195","document":"wf-form4_164081270887814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000195/wf-form4_164081270887814.xml","form_type":"4"}},{"id":2456922,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:18:42.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":33000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":15.44,"underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001399529-21-000195","document":"wf-form4_164081270887814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000195/wf-form4_164081270887814.xml","form_type":"4"}},{"id":2456921,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:18:42.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":14.76,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001399529-21-000195","document":"wf-form4_164081270887814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000195/wf-form4_164081270887814.xml","form_type":"4"}},{"id":2456920,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:18:42.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":14.13,"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001399529-21-000195","document":"wf-form4_164081270887814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000195/wf-form4_164081270887814.xml","form_type":"4"}},{"id":2456919,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-29T21:18:42.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each Issuer RSU that was then outstanding was cancelled and converted into the right to receive a cash payment equal to (A) the Offer Price multiplied by (B) the total number of Shares subject to such Issuer RSU immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each Issuer RSU that was then outstanding was cancelled and converted into the right to receive a cash payment equal to (A) the Offer Price multiplied by (B) the total number of Shares subject to such Issuer RSU immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each Issuer RSU that was then outstanding was cancelled and converted into the right to receive a cash payment equal to (A) the Offer Price multiplied by (B) the total number of Shares subject to such Issuer RSU immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001399529-21-000195","document":"wf-form4_164081270887814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000195/wf-form4_164081270887814.xml","form_type":"4"}},{"id":2456918,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-29T21:18:42.000Z","date":"2021-12-28","kind":"other","acquired":false,"shares":4666,"price":38.25,"value":178474.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001399529-21-000195","document":"wf-form4_164081270887814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000195/wf-form4_164081270887814.xml","form_type":"4"}},{"id":2477382,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2021-12-10T23:56:22.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":2.99,"expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-21-012696","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299321012696/form4.xml","form_type":"4"}},{"id":2535460,"issuer":{"id":112383,"kind":"organization","name":"Ampio Pharmaceuticals, Inc.","symbol":"AMPE"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-25T10:59:20.000Z","date":"2021-10-21","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as to 1/36 of the underlying shares monthly on the 13th day of each month for three years (until October 13, 2024). The vesting commencement date is October 13, 2021."}],"balance_after":150000,"derivative":{"exercise_price":1.67,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-21-004956","document":"form4-10252021_071011.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411906/000141588921004956/form4-10252021_071011.xml","form_type":"4"}},{"id":2679032,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-08T01:33:46.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the option will vest in full on the next regularly scheduled annual meeting of the stockholders of the Issuer that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting."}],"balance_after":15000,"derivative":{"exercise_price":30.47,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001399529-21-000106","document":"wf-form4_162311601071532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000106/wf-form4_162311601071532.xml","form_type":"4"}},{"id":2679031,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-08T01:33:46.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RSUs that shall vest and become nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on the earlier of (i) 12 months from June 3, 2021 (\"Grant Date\") and (ii) the next regularly scheduled annual meeting of stockholders of the Issuer that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer as a director through such date or, if earlier, such annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RSUs that shall vest and become nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on the earlier of (i) 12 months from June 3, 2021 (\"Grant Date\") and (ii) the next regularly scheduled annual meeting of stockholders of the Issuer that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer as a director through such date or, if earlier, such annual meeting."}],"balance_after":3333,"derivative":{"underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001399529-21-000106","document":"wf-form4_162311601071532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000106/wf-form4_162311601071532.xml","form_type":"4"}},{"id":2679030,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-08T01:33:46.000Z","date":"2021-06-03","kind":"exercise","acquired":false,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RSUs that vested and became nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on June 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RSUs that vested and became nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on June 3, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001399529-21-000106","document":"wf-form4_162311601071532.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000106/wf-form4_162311601071532.xml","form_type":"4"}},{"id":2679029,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T01:33:46.000Z","date":"2021-06-03","kind":"exercise","acquired":true,"shares":4666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":4666,"source":{"system":"sec-edgar","filing":"0001399529-21-000106","document":"wf-form4_162311601071532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000139952921000106/wf-form4_162311601071532.xml","form_type":"4"}},{"id":2723247,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T18:06:10.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":46218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 5, 2020 the reporting person was granted 46,218 restricted stock units vesting on May 6, 2021."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46218},"source":{"system":"sec-edgar","filing":"0001209191-21-030806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030806/doc4.xml","form_type":"4"}},{"id":2723246,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-07T18:06:10.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":35406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":35406,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35406},"source":{"system":"sec-edgar","filing":"0001209191-21-030806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030806/doc4.xml","form_type":"4"}},{"id":2723245,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-07T18:06:10.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":46218,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":70085,"source":{"system":"sec-edgar","filing":"0001209191-21-030806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000120919121030806/doc4.xml","form_type":"4"}},{"id":2725339,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-06T23:21:38.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares underlying this option will vest on 4/4/2021, 5/4/2021 and 5/19/2021."}],"balance_after":31250,"derivative":{"exercise_price":4.31,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001209191-21-030738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121030738/doc4.xml","form_type":"4"}},{"id":2725338,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-06T23:21:38.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares will vest on 5/19/2021."}],"balance_after":4167,"source":{"system":"sec-edgar","filing":"0001209191-21-030738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919121030738/doc4.xml","form_type":"4"}},{"id":2948838,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2020-12-11T21:59:24.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":23601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on the day prior to each of the Issuer???s next three annual stockholder meetings occurring immediately following the date of grant."}],"balance_after":23601,"derivative":{"exercise_price":2.98,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":23601},"source":{"system":"sec-edgar","filing":"0001062993-20-006261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299320006261/form4.xml","form_type":"4"}},{"id":3008533,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-13T20:55:32.000Z","date":"2020-10-08","kind":"grant","acquired":true,"shares":146190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option will vest on September 21, 2022, subject to the Reporting Person's continuous service to the Issuer through such date; vesting of all shares subject to the option shall vest upon a change of control."}],"balance_after":146190,"derivative":{"exercise_price":2.76,"expiration_date":"2030-10-08","underlying":"Common Stock","underlying_shares":146190},"source":{"system":"sec-edgar","filing":"0001209191-20-054667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000120919120054667/doc4.xml","form_type":"4"}},{"id":3108670,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-17T00:03:35.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the option vests in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":21000,"derivative":{"exercise_price":21.61,"expiration_date":"2030-06-14","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000899243-20-016731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000089924320016731/doc4.xml","form_type":"4"}},{"id":3108669,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-17T00:03:35.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":4666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest 12 months from June 15, 2020 (\"Grant Date\"), provided that these RSUs vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through such vesting date or, if earlier, such annual meeting. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest 12 months from June 15, 2020 (\"Grant Date\"), provided that these RSUs vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through such vesting date or, if earlier, such annual meeting. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest 12 months from June 15, 2020 (\"Grant Date\"), provided that these RSUs vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through such vesting date or, if earlier, such annual meeting. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":4666,"derivative":{"underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0000899243-20-016731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000089924320016731/doc4.xml","form_type":"4"}},{"id":3158170,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-07T21:23:34.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 6, 2019, the reporting person was granted 6,459 restricted stock units vesting on May 7, 2020."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0000899243-20-012257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/doc4.xml","form_type":"4"}},{"id":3158169,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-07T21:23:34.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":46218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":46218,"derivative":{"underlying":"Class A Common Stock","underlying_shares":46218},"source":{"system":"sec-edgar","filing":"0000899243-20-012257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/doc4.xml","form_type":"4"}},{"id":3158168,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-05-07T21:23:34.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":6459,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":23867,"source":{"system":"sec-edgar","filing":"0000899243-20-012257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/doc4.xml","form_type":"4"}},{"id":3388361,"issuer":{"id":144844,"kind":"organization","name":"BIOSPECIFICS TECHNOLOGIES CORP","symbol":"BSTC"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-25T16:47:05.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest ratably over the four-year period following the date of grant, October 23, 2019, subject to the Reporting Person's continued service to the employer through the vesting date.  In the event the Reporting Person is terminated (a) by the employer without cause, (b)  by the Reporting Person for good reason, or (c) by the employer without cause or by the Reporting Person for good reason, in each case upon or within one (1) year following a change of control, the stock options will fully vest."}],"balance_after":85000,"derivative":{"exercise_price":46.52,"expiration_date":"2029-10-23","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001062993-19-004037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875622/000106299319004037/form4.xml","form_type":"4"}},{"id":3481085,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-22T00:00:55.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly over 12 months from June 20, 2019 (\"Grant Date\") in substantially equal monthly installments, provided that the option will vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each such date or, if earlier, such annual meeting."}],"balance_after":33000,"derivative":{"exercise_price":15.44,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0000899243-19-017860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000089924319017860/doc4.xml","form_type":"4"}},{"id":3535261,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:50:09.000Z","date":"2019-05-08","kind":"exercise","acquired":false,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 7, 2018, the reporting person was granted 6,107 restricted stock units vesting on May 8, 2019."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0001723128-19-000074","document":"wf-form4_155735219336381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/wf-form4_155735219336381.xml","form_type":"4"}},{"id":3535260,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-08T21:50:09.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":6459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.  Restricted stock units have no expiration date."}],"balance_after":6459,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6459},"source":{"system":"sec-edgar","filing":"0001723128-19-000074","document":"wf-form4_155735219336381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/wf-form4_155735219336381.xml","form_type":"4"}},{"id":3535259,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-08T21:50:09.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on the later of (i) the day immediately preceeding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant."}],"balance_after":28044,"derivative":{"exercise_price":14.05,"expiration_date":"2029-05-06","underlying":"Class A Common Stock","underlying_shares":28044},"source":{"system":"sec-edgar","filing":"0001723128-19-000074","document":"wf-form4_155735219336381.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/wf-form4_155735219336381.xml","form_type":"4"}},{"id":3535258,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-08T21:50:09.000Z","date":"2019-05-08","kind":"exercise","acquired":true,"shares":6107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":17408,"source":{"system":"sec-edgar","filing":"0001723128-19-000074","document":"wf-form4_155735219336381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/wf-form4_155735219336381.xml","form_type":"4"}},{"id":3574103,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-03-30T00:00:33.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to one-third of the underlying shares on the one year anniversary of the date of grant and as to the remaining two-thirds of the shares in quarterly installments over the two-year period thereafter, subject in each case to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8000,"derivative":{"exercise_price":14.13,"expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000899243-19-009327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000089924319009327/doc4.xml","form_type":"4"}},{"id":3843161,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-08-16T01:02:38.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to one-third of the underlying shares on the one year anniversary of the date of grant and as to the remaining two-thirds of the shares in quarterly installments over the two-year period thereafter, subject in each case to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":14.76,"expiration_date":"2028-08-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000905148-18-000717","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1209726/000090514818000717/form4.xml","form_type":"4"}},{"id":3942744,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-08T23:26:12.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":6107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."}],"balance_after":6107,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6107},"source":{"system":"sec-edgar","filing":"0000899243-18-011948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011948/doc4.xml","form_type":"4"}},{"id":3942743,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:26:12.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":24977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in four equal annual installments beginning on May 07, 2019."}],"balance_after":24977,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":24977},"source":{"system":"sec-edgar","filing":"0000899243-18-011948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011948/doc4.xml","form_type":"4"}},{"id":3942742,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:26:12.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":20445,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":20445,"derivative":{"exercise_price":14.45,"expiration_date":"2026-11-23","underlying":"Class A Common Stock","underlying_shares":20445},"source":{"system":"sec-edgar","filing":"0000899243-18-011948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011948/doc4.xml","form_type":"4"}},{"id":3942741,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-05-08T23:26:12.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":7931,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":7931,"derivative":{"exercise_price":16.4,"expiration_date":"2027-05-16","underlying":"Class A Common Stock","underlying_shares":7931},"source":{"system":"sec-edgar","filing":"0000899243-18-011948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011948/doc4.xml","form_type":"4"}},{"id":3942740,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-05-08T23:26:12.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":11301,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 11,301 shares of Impax Laboratories, Inc. (\"Impax\") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the \"BCA\")."}],"balance_after":11301,"source":{"system":"sec-edgar","filing":"0000899243-18-011948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011948/doc4.xml","form_type":"4"}},{"id":3943113,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:23:17.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":20445,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":14.45,"expiration_date":"2026-11-23","underlying":"Common Stock","underlying_shares":20445},"source":{"system":"sec-edgar","filing":"0001003642-18-000085","document":"wf-form4_152581093204247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000085/wf-form4_152581093204247.xml","form_type":"4"}},{"id":3943112,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:23:17.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":7931,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":16.4,"expiration_date":"2027-05-16","underlying":"Common Stock","underlying_shares":7931},"source":{"system":"sec-edgar","filing":"0001003642-18-000085","document":"wf-form4_152581093204247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000085/wf-form4_152581093204247.xml","form_type":"4"}},{"id":3943111,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Common Stock","published_at":"2018-05-08T16:23:17.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":3281,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares of restricted common stock disposed of pursuant to the terms of the BCA, according to which each share of restricted stock held by the reporting person fully vested and was exchanged for one share of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of restricted common stock disposed of pursuant to the terms of the BCA, according to which each share of restricted stock held by the reporting person fully vested and was exchanged for one share of Class A Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001003642-18-000085","document":"wf-form4_152581093204247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000085/wf-form4_152581093204247.xml","form_type":"4"}},{"id":3943110,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-08T16:23:17.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":8020,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common Stock disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017 (the \"BCA\"), by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017, according to which each share of Common Stock held by the reporting person was converted into the right to receive one share of Class A common stock of Holdco (\"Class A Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017 (the \"BCA\"), by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017, according to which each share of Common Stock held by the reporting person was converted into the right to receive one share of Class A common stock of Holdco (\"Class A Common Stock\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001003642-18-000085","document":"wf-form4_152581093204247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000085/wf-form4_152581093204247.xml","form_type":"4"}},{"id":4316498,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2017-05-17T15:50:49.000Z","date":"2017-05-16","kind":"grant","acquired":true,"shares":7931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option fully vests on the earlier of (i) May 16, 2018, which is the first anniversary of the date of grant and (ii) one day before the date of the Company's next annual meeting of stockholders."}],"balance_after":7931,"derivative":{"exercise_price":16.4,"expiration_date":"2027-05-16","underlying":"Common Stock","underlying_shares":7931},"source":{"system":"sec-edgar","filing":"0001003642-17-000055","document":"wf-form4_149505063540951.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000055/wf-form4_149505063540951.xml","form_type":"4"}},{"id":4316497,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-17T15:50:49.000Z","date":"2017-05-16","kind":"grant","acquired":true,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11301,"source":{"system":"sec-edgar","filing":"0001003642-17-000055","document":"wf-form4_149505063540951.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000055/wf-form4_149505063540951.xml","form_type":"4"}},{"id":4541446,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2016-11-28T16:52:08.000Z","date":"2016-11-23","kind":"grant","acquired":true,"shares":20445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option fully vests on the earlier of (i) November 23, 2017, which is the first anniversary of the date of grant and (ii) one day before the date of the Company's next annual meeting of stockholders."}],"balance_after":20445,"derivative":{"exercise_price":14.45,"expiration_date":"2026-11-23","underlying":"Common Stock","underlying_shares":20445},"source":{"system":"sec-edgar","filing":"0001003642-16-000051","document":"wf-form4_148036991544071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364216000051/wf-form4_148036991544071.xml","form_type":"4"}},{"id":4541445,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":23704,"kind":"person","name":"BUCHI J KEVIN","position":1,"cik":"0001209726","reported_name":"BUCHI J KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T16:52:08.000Z","date":"2016-11-23","kind":"grant","acquired":true,"shares":8020,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8020,"source":{"system":"sec-edgar","filing":"0001003642-16-000051","document":"wf-form4_148036991544071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364216000051/wf-form4_148036991544071.xml","form_type":"4"}}]}